Open AccessPlasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension
Author(s) -
Christopher J. Rhodes,
Pavandeep Ghataorhe,
John Wharton,
Kévin Rue-Albrecht,
Charaka Hadinnapola,
G.K. Watson,
Marta Bleda,
Matthias Haimel,
Gerry Coghlan,
Paul A. Corris,
Luke Howard,
David G. Kiely,
Andrew J. Peacock,
Joanna PepkeŻaba,
Mark Toshner,
Stephen J. Wort,
J. Simon R. Gibbs,
Allan Lawrie,
Stefan Gräf,
Nicholas W. Morrell,
Martin R. Wilkins
Publication year - 2016
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.116.024602
Subject(s) - medicine , metabolomics , bioenergetics , pulmonary hypertension , cardiology , intensive care medicine , bioinformatics , mitochondrion , microbiology and biotechnology , biology
Pulmonary arterial hypertension (PAH) is a heterogeneous disorder with high mortality.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom